NAMS' New Hormone Therapy Position Statement: Clinical Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - August 15, 2017 Category: General Medicine Authors: Medscape Source Type: podcasts

NAMS' Hormone Therapy Statement: Primary Care Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - August 15, 2017 Category: OBGYN Authors: Medscape Source Type: podcasts

NAMS' New Hormone Therapy Position Statement: Clinical Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - August 15, 2017 Category: General Medicine Authors: Medscape Source Type: podcasts

What to Know About the NAMS Updated Position on Hormone Therapy
Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - July 17, 2017 Category: General Medicine Authors: Medscape Source Type: podcasts

What to Know About the NAMS Updated Position on Hormone Therapy
Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - July 17, 2017 Category: OBGYN Authors: Medscape Source Type: podcasts

How Menopausal Hormone Therapy Could Reduce Alzheimer's Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the ' critical window ' hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

Menopausal Hormone Therapy and Alzheimer Disease Risk
Dr Andrew Kaunitz describes results of a recent population-based study that supports the ' critical window ' hypothesis of hormone therapy after menopause. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 28, 2017 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts

An Update on Hormonal Therapy for Advanced Prostate Cancer
Are there recent advances in treating advanced prostate cancer patients with hormonal therapy? Listen as a panel of experts, including Dr. Tomasz Beer, Dr. Russell Szmulewitz, Dr. Emmanuel Antonarakis... Author: patientpower Added: 09/08/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 8, 2016 Category: Cancer & Oncology Source Type: podcasts

An Overview of Hormonal Therapy Options for Advanced Prostate Cancer
Expert Dr. Russell Szmulewitz of the University of Chicago Medical Center describes the endocrinology of prostate cancer and provides an overview of hormonal therapies. Dr. Szmulewitz examines the cha... Author: P2Professional Added: 06/20/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2016 Category: Cancer & Oncology Source Type: podcasts

An Overview of Hormonal Therapy Options for Advanced Prostate Cancer
Expert Dr. Russell Szmulewitz of the University of Chicago Medical Center describes the endocrinology of prostate cancer and provides an overview of hormonal therapies. Dr. Szmulewitz examines the cha... Author: patientpower Added: 06/15/2016 (Source: Oncology Tube)
Source: Oncology Tube - June 15, 2016 Category: Cancer & Oncology Source Type: podcasts

ELITE Provides Reassurance About Estrogen in Early Menopause
The just-published ELITE trial suggests that coronary risk should not be a justification to deny hormone therapy to appropriate candidates in early menopause. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - April 6, 2016 Category: OBGYN Authors: Medscape Source Type: podcasts

ECC 2015: Press programme with updates on post-diagnosis aspirin use, Combi-v, and hormonal therapy in breast cancer
At the European Cancer Congress (ECC) 2015, Peter Naredi, MD, PhD, of the University of Gothenburg, Gothenburg, Sweden, chairs a news briefing with Matteo Lambertini, MD, of IRCCS AOU San Martino-IST,... Author: EMJ Added: 10/08/2015 (Source: Oncology Tube)
Source: Oncology Tube - October 8, 2015 Category: Cancer & Oncology Source Type: podcasts

ECC 2015: Hormonal therapy may prevent ovarian failure and preserve fertility in breast cancer
A meta-analysis was conducted to include 12 randomised trials and a total of 1,231 breast cancer patients receiving chemotherapy, with or without luteinising hormone-releasing hormone analogue (LHRHa)... Author: EMJ Added: 10/06/2015 (Source: Oncology Tube)
Source: Oncology Tube - October 6, 2015 Category: Cancer & Oncology Source Type: podcasts